
Grifols, S.A (GRF) | Financial Analysis & Statements
Grifols, S.A. | Large-cap | Healthcare
Grifols, S.A. | Large-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
7.2B
Gross Profit
2.8B
38.75%
Operating Income
1.2B
16.02%
Net Income
212.8M
2.95%
Balance Sheet Metrics
Total Assets
21.4B
Total Liabilities
12.8B
Shareholders Equity
8.6B
Debt to Equity
1.49
Cash Flow Metrics
Operating Cash Flow
1.6B
Free Cash Flow
530.8M
Revenue & Profitability Trend
Grifols, S.A Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 7.2B | 6.6B | 6.1B | 4.9B | 5.3B |
Cost of Goods Sold | 4.4B | 4.1B | 3.8B | 3.0B | 3.1B |
Gross Profit | 2.8B | 2.5B | 2.2B | 2.0B | 2.3B |
Operating Expenses | 1.6B | 1.8B | 1.4B | 1.3B | 1.3B |
Operating Income | 1.2B | 718.6M | 702.2M | 562.5M | 975.3M |
Pre-tax Income | 444.0M | 207.0M | 361.3M | 350.5M | 878.6M |
Income Tax | 231.2M | 43.3M | 90.1M | 85.1M | 169.6M |
Net Income | 212.8M | 163.7M | 271.1M | 265.3M | 709.0M |
EPS (Diluted) | - | €0.06 | €0.31 | €0.27 | €0.90 |
Income Statement Trend
Grifols, S.A Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | 5.7B | 6.1B | 4.7B | 5.5B | 3.2B |
Non-Current Assets | 15.7B | 14.9B | 16.9B | 13.7B | 12.1B |
Total Assets | 21.4B | 21.0B | 21.5B | 19.2B | 15.3B |
Liabilities | |||||
Current Liabilities | 2.2B | 2.3B | 2.0B | 3.5B | 1.3B |
Non-Current Liabilities | 10.6B | 11.2B | 11.1B | 8.4B | 7.2B |
Total Liabilities | 12.8B | 13.5B | 13.1B | 11.9B | 8.6B |
Equity | |||||
Total Shareholders Equity | 8.6B | 7.5B | 8.5B | 7.3B | 6.7B |
Balance Sheet Composition
Grifols, S.A Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 444.0M | 207.0M | 361.3M | 350.5M | 878.6M |
Operating Cash Flow | 1.6B | 743.0M | 485.4M | 742.3M | 1.5B |
Investing Activities | |||||
Capital Expenditures | -209.0M | -201.2M | -263.2M | -246.7M | -279.9M |
Investing Cash Flow | 1.0B | -308.8M | -1.9B | -786.4M | -775.7M |
Financing Activities | |||||
Dividends Paid | -962.0K | 0 | -592.0K | -258.9M | -113.2M |
Financing Cash Flow | -1.4B | 171.5M | -173.5M | 2.3B | -245.9M |
Free Cash Flow | 530.8M | -91.6M | -386.4M | 281.9M | 747.8M |
Cash Flow Trend
Grifols, S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
44.04
Forward P/E
17.17
Price to Book
1.22
Price to Sales
0.86
PEG Ratio
17.17
Profitability Ratios
Profit Margin
2.65%
Operating Margin
16.42%
Return on Equity
3.45%
Return on Assets
3.99%
Financial Health
Current Ratio
2.60
Debt to Equity
121.14
Beta
1.00
Per Share Data
EPS (TTM)
€0.23
Book Value per Share
€8.29
Revenue per Share
€10.84
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
grf | 6.4B | 44.04 | 1.22 | 3.45% | 2.65% | 121.14 |
Aperam S.A | 2.0B | 8.21 | 0.57 | 6.93% | 3.71% | 42.53 |
Construcciones y | 1.6B | 15.30 | 1.79 | 11.52% | 2.68% | 101.56 |
Tecnicas Reunidas | 1.5B | 15.11 | 2.32 | 16.86% | 2.03% | 101.42 |
Bankinter S.A | 9.8B | 9.80 | 1.68 | 17.81% | 39.06% | 1.58 |
Financial data is updated regularly. All figures are in the company's reporting currency.